Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) Return on Sales (2020 - 2025)

Historic Return on Sales for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to 0.2%.

  • P3 Health Partners' Return on Sales rose 800.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.21% for FY2024, which is 600.0% down from last year.
  • Per P3 Health Partners' latest filing, its Return on Sales stood at 0.2% for Q3 2025, which was up 800.0% from 0.12% recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Return on Sales peaked at 0.08% during Q2 2024, and registered a low of 3.35% during Q2 2022.
  • Over the past 5 years, P3 Health Partners' median Return on Sales value was 0.2% (recorded in 2025), while the average stood at 0.46%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -31500bps in 2022, then soared by 32700bps in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Return on Sales stood at 0.48% in 2021, then plummeted by -333bps to 2.06% in 2022, then surged by 90bps to 0.2% in 2023, then plummeted by -75bps to 0.35% in 2024, then skyrocketed by 42bps to 0.2% in 2025.
  • Its Return on Sales stands at 0.2% for Q3 2025, versus 0.12% for Q2 2025 and 0.12% for Q1 2025.